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Murine  macrophages  synthesize  specific  cyclo-oxygenase and  lipoxygenase 
metabolites of arachidonic acid (20:4) 1 after stimulation with zymosan (1-3) or 
particles coated with immune complexes of immunoglobulin G  or E  (4,  5).  In 
man, less is known about the spectrum of oxygenated 20:4 compounds produced 
by  mononuclear  phagocytes.  A  number  of studies  have  examined  the  cyclo- 
oxygeanse products of the human monocyte (6-1 1), the blood-borne precursor 
of the tissue macrophage. In addition, the synthesis of the lipoxygenase metab- 
olite leukotriene B4 by the human alveolar macrophage has been reported (12). 
A particular problem in the study of 20:4 metabolism by the human monocyte 
has been platelet contamination. We now report a  means of removing platelets 
adherent to the surfaces of freshly isolated monocytes. As a  result, quantitative 
and qualitative comparisons of the biosynthetic pathways of platelets and mono- 
cytes were possible. Thromboxane was the predominant metabolite of monocytes 
incubated with particulate stimuli whereas exposure  to the calcium ionophore 
A23187 yielded chiefly lipoxygenase products. 
Materials and Methods 
Human  Peripheral Blood  Components.  Leukocyte concentrates prepared from ACD-A 
anticoagulated whole blood were obtained from The New York Blood Center, New York, 
NY. Whole blood was obtained from healthy human volunteers after informed consent 
and collected into heparin (20 U/ml) or EDTA (final concentration 5 mM). 
Materials.  [5,6,8,9,11,12,14,15-SH]20:4  ([SH]20:4)  (78.2-91.5  Ci/mmol sp act) was 
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1  Abbreviations used in this paper: 20:4, arachidonic acid; A23187, calcium ionophore A23187; D- 
M, detached monocyte culture; [SH]20:4, [5,6,8,9,1-1,12,13,15-SH]20:4; HETE, hydroxy-eicosate- 
traenoic acid; 5-HETE, 5-hydroxy-6,8,11,14-eicosatetraenoic  acid; 12-HETE, 12-hydroxy-5,8,10,14- 
eicosatetraenoic acid; 15-HETE, 15-hydroxy-5,8,11,13-eicosatetraenoic  acid; HPLC, high pressure 
liquid chromatography; Ig-beads, immunoglobulin  G complex-coated  Sephadex beads; 6-keto PGFxo, 
6-keto prostaglandin Fta; leukotriene B4, 5(S)-  12(R)-dihydroxy-6,8,10,14-c/s, trans, tram, c/s-eicosa- 
tetraenoic acid; leukotriene C4, 5(S)-hydroxy-6(R)-S-~,-glutamylcysteinylglycyl-7,9,11,14-eicosatetrae- 
noic acid; M-P, monocyte-platelet  culture; OpZ, opsonized zymosan;  PBS, phosphate-buffered  saline; 
PD, calcium- and magnesium-free phosphate-buffered saline; PGE,, prostaglandin E~; PGF2~, pros- 
taglandin F~,; SEM, scanning electron microscopy; SW-M, serum-washed monocyte culture; TLC, 
thin-layer chromatography; TXB~, thromboxane B2. 
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purchased from New England Nuclear, Boston, MA. [5,8,9,11,12,14,15-3H]  6-keto pros- 
taglandin F~,,  [5,6,8,9,11,12,14,15-3H]  thromboxane B2, [5,6,8,9,11,12,14,15-3H]  pros- 
taglandin F2~, and [5,6,8,11,12,14,15-~H] prostaglandin E~ were all purchased from New 
England Nuclear (all  120-200 Ci/mmoi sp act). Hydrofluor was obtained from National 
Diagnostics,  Inc.,  Somerville,  NJ.  FicolI-Paque  was  purchased  from  Pharmacia  Fine 
Chemicals, Piscataway, NJ. Calcium ionophore A23187 was obtained from Calbiochem- 
Behring Corp.,  La Jolla, CA. Serum lipid,  Redi-Coat G, and Redi-Coat-2D plates were 
purchased from Supelco, Inc., Bellefonte, PA. HPLC solvents were either HPLC grade 
or distilled  before  use.  Zymosan was  purchased  from  ICN  K  &  K  Laboratories Inc., 
Plainview, NY and trypan blue 0.4%  in 0.9%  NaC1 (wt/vol) from Gibco Laboratories, 
Grand Island, NY. Triton X-100 was obtained from Rohm and Haas Co., Philadelphia, 
PA. Gas-liquid chromatography columns were purchased from Supelco, Inc., Bellefonte, 
PA.  Heparin (Lipo-Hepin) was obtained from Riker Laboratories, Northridge, CA and 
Sephadex G-25-40 beads (10-40 #m) were from Sigma Chemical Co., St. Louis, MO. 
Culture Media and Serum.  Adherent cells were cultured in RPMI 1640 supplemented 
with  100 U/ml penicillin G and  100 #g/ml streptomycin (Gibco Laboratories) and  10- 
15%  human  serum.  Whole A+ blood was collected without additives (The New York 
Blood Center) for preparation of the serum used throughout these studies. After 2-4 h 
at 4 °  C, clotted blood was centrifuged and the serum supernate filtered (0.45 #M). Aliquots 
of serum were stored at -20°C before use. 
Preparation of Particles.  Zymosan was prepared as described (1) and was opsonized by 
incubation at 37°C for 20 min in fresh human serum diluted in normal saline (1:1, voi/ 
vol). The opsonized particles (OpZ) were washed twice and resuspended in RPMI  1640 
before use.  IgG immune complex-coated Sephadex beads (Ig-beads) were prepared as 
described previously (4). Sephadex beads containing covalently bound DNP-albumin were 
the  generous  gift of Dr.  Carol  A.  Rouzer  (The  Rockefeller University).  Immediately 
before  use,  IgG  immune  complexes  were  formed  on  the  surfaces  of  DNP-aibumin 
Sephadex beads by incubation with 100 #g/ml of rabbit anti-DNP IgG at 4 °C for 45 min. 
The beads were washed three times before resuspension in medium. 
Isolation of Adherent Monocytes.  Leukocyte concentrates or anticoagulated whole blood 
was diluted with cold phosphate-buffered isotonic saline lacking calcium and magnesium 
(PD)  (1:1,  vol/vol) and  centrifuged at  125-150  g  for 20  min at  4°C.  All  subsequent 
procedures  were  carried  out  at  4°C  unless  otherwise  specified.  The  supernate  was 
discarded and the cell pellet was washed again in PD. The cells were resuspended in PD 
containing 0.3  mM  EDTA and layered on top of FicolI-Paque (1.5:1,  cell suspension/ 
Ficoll°Paque, vol/vol) before centrifugation at 800 g for 25 rain at 23 °C (13). The aliquot 
containing  the  mononuclear cells  at  the  gradient  interface  was  diluted  with  PD  and 
pelleted. Two further washes using PD were performed. Mononuclear cells thus isolated 
were used for establishment of adherent monocyte cultures designated monocyte-platelet 
(M-P) or processed further to remove monocyte-associated platelets. 
To remove platelets specifically adherent to monocytes, gradient-isolated mononuclear 
cells were resuspended in serum containing 5 mM EDTA (0.7 ml of 77 mM EDTA added 
per 10 mi of serum) and subjected to two sequential incubations (10-15 rain) at 37 °C. 10 
ml of serum was used per  1-2  ×  108 mononuclear cells in  15-ml polyethylene conical 
tubes  for  each  incubation.  The  cell  pellets  and  mononuclear  cells  were  thoroughly 
resuspended at the start and end of each incubation.  Mononuclear cells were recovered 
by centrifugation  at  400 g  for  15  rain  (23°C).  The  purified  mononuclear cells  were 
resuspended in PD and washed twice at 4°C before plating. Cell counts, cell viability, and 
cytocentrifugation  were  performed  before  and  after  the  serum  treatment  step.  Cell 
viabilities were routinely ~98% and total cell and monocyte recoveries were each 90% or 
greater for this procedure. 
For the final isolation of monocytes by adherence, mononuclear cell suspensions washed 
with PD alone (M-P) or additionally washed in serum-EDTA (serum-washed monocytes, 
SW-M) were resuspended in medium containing  15% serum (8-10 ×  106 mononuclear 
ceils/ml) and incubated in  sterile 35  mm (1  ml) or 60  mm diam (3  mi) plastic culture 
dishes for 1-2 h. All incubations were in an atmosphere of 5% CO2/95% air at 37 °C. Non- PAWLOWSKI  ET  AL.  395 
adherent  cells  were  removed  by  three  washes  with  warm  phosphate-buffered  saline 
containing calcium and magnesium (PBS)  before incubation with radiolabel or morpho- 
logic examination. 
Detachment ofSW-M Monolayers.  SW-M could be detached from plastic culture dishes 
immediately after the  initial  adherence  period.  Before detachment,  monolayers were 
washed thoroughly with PBS to remove nonadherent cells.  Monocytes were detached by 
incubation in PD (37 °C) for several minutes and gentle repipetting using plastic labware. 
Viabilities of detached monocytes were >90%.  Monocytes readily readbered in medium 
containing serum (5%). The resulting monolayers (detached monocyte, D-M) showed the 
same functional characteristics (ingestion of zymosan) as SW-M. Adherent monocytes in 
platelet-contaminated cultures (M-P) do not detach when incubated in PD under the same 
conditions. 
Microscopic Examination of Monocyte Cultures.  Cultures  of adherent  monocytes were 
established on acid-washed glass coverslips as described above for M-P and SW-M cultures. 
After removal of nonadherent ceils by PBS washes, coverslips were further incubated in 
medium with 10% serum for 4 h before examinations by microscopy. >99% of adherent 
cells (SW-M and  D-M) thus  obtained  showed  typical morphology of monocytes upon 
Wright's staining as well as positive reactions for esterase (14) and peroxidase (15).  In 
addition, >99% of the adherent cells were judged viable after incubation with trypan blue 
and 95% of individual cells ingested two or more opsonized zymosan particles within 60 
min. 
For scanning electron microscopy, cells on coverslips were fixed in  1.25% gluteralde- 
hyde in 0.1  M  sodium cacodylate, washed, dehydrated in ethanol,  transferred to amyl 
acetate, and critical point dried  (Hitachi CTI, Tokyo, Japan) in  CO2.  Specimens were 
coated with gold (Polaron EM coating unit, E5000; Polaron Instruments Inc., Doylestown, 
PA) and examined with a  high resolution Hitachi scanning electron microscope (HHS/ 
2R) at 20 kV, at a tilt angle of 30 ° (16). 
Adherent Platelet Cultures.  Whole heparinized blood was centrifuged at 150 g for 15 
min at 23°C. The platelet-rich plasma was removed and diluted to 10-20% with medium, 
warmed to 37 °  C, and thoroughly resuspended. Aliquots of the diluted platelet-rich plasma 
were incubated on 35 mm (1  ml) or 60 mm diam (3 ml) plastic culture dishes for 1 to 2 
h. Adherent mon01ayers were washed three times with PD before incubation with radiolabel. 
Adherent monolayers were nearly confluent and well-spread. A small percentage of the 
initially adherent  platelets  became rounded  and  loosely adherent  over time but  were 
effectively washed away before stimulation. 
20:4 Metabolism.  Immediately after the 2-h adherence period, the washed monocyte 
and platelet cultures were incubated for 4  h  in medium containing  10% serum and 0.5 
#Ci/ml of [3H]20:4.  Aliquots of medium were taken before and after incubation  with 
cells and the percent uptake of radiolabel was calculated from the decrease in radioactivity 
of the culture medium as determined by liquid scintillation counting. At the end of the 
labeling period, cultures were washed three times with PBS and overlaid with medium 
without serum. Calcium ionophore A23187 was added directly to cultures as an ethanol 
solution (final ethanol concentration, 0.5%). Ethanol added alone was not found to alter 
cell morphology, viability, or the spontaneous release of incorporated [SH]20:4. OpZ was 
added to cultures at 160 #g/mi and Ig-beads suspended in medium were added to cultures 
in quantities sufficient to entirely cover the adherent cell monolayer. 
After  the  specified incubation  periods,  medium  was  removed  from culture  dishes, 
placed on  ice,  and  maintained  under a  nitrogen  atmosphere.  Aiiquots  of media  were 
taken for determination of radiolabel contents after centrifugation to remove debris. For 
each  experiment,  triplicate  or  quadruplicate  control  cultures  given  no  stimulus  were 
included.  In each,  the spontaneous release of radiolabei into medium was determined. 
After the removal of medium, control cell monolayers were washed three times with PBS 
and scraped into 0.05% Triton X-100. Aliquots of cell lysates were used for determination 
of total protein  (17) and radioactivity contents.  For each experiment, control cultures 
were used to establish the total protein and total radiolabel contents of replicate culture 
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radiolabel content of the medium of stimulated cultures and the total radiolabel content 
of control cultures. 
Medium  from stimulated  cultures was  centrifuged (150 g  for  10  min  at  8°C)  and 
transferred to separate tubes.  20:4 and its oxygenated metabolites were extracted by a 
modification of the procedure described by Unger et ai. (18). In brief, 1 voi of ethanol 
was added and the mixture was acidified to pH  ~3.0 with formic acid. Extraction was 
performed twice with  1 vol each of chloroform and the organic phases were pooled. 
Recoveries of radiolabel from the medium were routinely >85%. The extracts were dried 
to nil under reduced pressure or a stream of nitrogen. After resuspension with washes of 
ethanol/water (4:1, vol/vol) and chloroform/methanol (2:1, vol/vol), extracts were dried 
again to remove traces of formic acid. 
Sepa ration of ~H-labeled Metabolites by High Pressure Liquid Chromatography (HPLC).  [3H]- 
20:4 metabolites extracted from media samples were separated and identified by HPLC 
using three systems. All samples were resuspended in 0.4 mi of the appropriate HPLC 
starting solvent before chromatography. (a) HPLC system 1. A column (4.6 ×  250 ram) 
of 5 ~m Ultrasphere ODS (Altex Scientific, Inc., Beckman Instruments, Inc., Berkeley, 
CA) was eluted at a  flow rate of 1 mi/min with 60 mi of methanol/water/acetic acid 
(75:25:0.01, vol/vol/vol) followed by 40 mi of methanol/acetic acid ( 100:0.01, vol/vol). 
In some experiments, the column effluent was monitored for UV absorbance at 240 nm 
using a Spectroflow Monitor SF-770 (Kratos, Schoeffel Instrument Division, Westwood, 
N  J). Fractions of 1 ml were collected. The contents of fractions were dried under a stream 
of air  and  the  radiolabel  content  of each  was  determined  in  Hydrofluor by  liquid 
scintillation counting.  Under these conditions, stable cyclo-oxygenase products [6-keto 
prostaglandin Fla (6-keto PGFI~), thromboxane B~ (TxB~), prostaglandin F2~ (PGF2~), and 
prostaglandin E~ (PGE~)] eluted at 4-10 min (19-21); di-hydroxy-eicosatetraenoic acids 
(di-HETEs) at  11-15 min (19-21),  12-hydroxy-heptadecatrienoic acid (HHT) at  16-18 
min,  mono-hydroxy-eicosatetraenoic acids  (mono-HETEs)at 25-50  min  (19-21),  and 
unreacted 20:4 at 71-78 rain. 
Mono-HETE standards were prepared as described previously (21). The molar quan- 
tities of 12-hydroxy-eicosatetraenoic acid (12-HETE) relative to 5-hydroxy-eicosatetrae- 
noic acid (5-HETE) were determined during HPLC from relative peak absorbances (240 
nm) of each compound. 
(b) In some experiments, HPLC system 2 was used for the initial separation of [3H]20:4 
metabolites. Reversed-phase columns identical to those used in system 1 were eluted at 1 
ml/min with 60 ml of methanol/water/acetic acid (65:35:0.1, vol/voi/voi, adjusted to 
pH  5.4 with  NH4OH), followed by 40 ml of methanol/water/acetic acid (75:25:0.01, 
vol/vol/vol), and finally 40 mi of methanol acetic acid (100:0.01, vol/vol). Under these 
conditions, stable cyclo-oxygenase  products (6 keto-PGFl~, TxB2, PGF~, and PGE2) elute 
at  10-18 min, di-HETEs at 30-55 min, HHT at 56-64 min, mono-HETEs at 85-105 
min, and unreacted 20:4 at 110-120 min. 
(c) For the identification of individual cycio-oxygenase  products, the contents of appro- 
priate fractions from HPLC system 1 (4-10 min) or HPLC system 2 (4-18 min) were 
pooled, dried under reduced pressure, and chromatographed using HPLC system 3. A 
Waters Fatty Acid Analysis column (3.9 mm x  30 cm) (Waters Associates,  Woburn, MA) 
was eluted isocratically at 2 ml/min with  100 ml of acetonitrile/water/benzene/acetic 
acid (76.7:23.0:0.2:0.1, vol/vol/vol/vol) (22) followed by 40 ml of methanol/acetic acid 
(100:0.01,  vol/vol). Identification of recovered radiolabeled cycio-oxygenase products 
was accomplished by comparison of retention times with authentic all-labeled standards. 
Using this system, consistent separation of 6-keto PGFI~ (9-12 min), TxB~ (22-25 min), 
PGF2, (27-30 min), and PGE~ (35-38 min) was obtained. 
Extraction and Separation of Cellular Lipids.  After the specified periods of incubation 
with [SH]20:4  in medium containing serum, cell monolayers were placed on ice, washed 
three times with isotonic saline, and extracted at 4°C following the procedure of Bligh 
and  Dyer  (23).  Lipid  extracts  were  concentrated  under  a  stream  of nitrogen.  For 
separation of neutral lipid, phospholipid, and free fatty acids, aliquots of lipid extracts 
were  spotted  onto  Redicoat  G  thin  layer chromatography (TLC) plates  prepared  as PAWLOWSKI ET AL.  397 
described (24) and developed with diethyl ether. Individual phospholipids were separated 
on Redicoat 2D TLC plates. Carrier lipid (serum lipid or cell extracts of the macrophage- 
like line J774) was added for the purpose of detection. Chromatograms were developed 
in the first dimension with chloroform/methanol/ammonium  hydroxide (65:35:5, vol/ 
vol/vol) and in the second dimension with chloroform/acetone/methanol/acetic  acid/ 
water (30:40:10:10:5,  vol/vol/vol/vol/vol) (25). Lipid-containing regions were visualized 
by a brief exposure of plates to iodine vapors and were scraped into scintillation vials. 
Radioactivity was determined in Hydrofluor after the addition of water. 
Total cell phospholipids  and neutral lipids were separated on columns of activated 
Unisil (0.4 g), and fatty acid methyl esters were prepared from the total phospholipid and 
neutral lipid fractions by transesterification in methanolic HCI (26). Methyl esters were 
then analyzed by gas-liquid chromatography on Vs-in x 6-ft columns of 10% SP-2330 on 
100/200 Chromosorb WA/A at 180°C with a carrier gas flow rate of 30 ml/min. 
Radioimmunoassay of TxB2.  Molar quantities of TxB~ in media extracts of appropriately 
stimulated  cultures  were  determined  with  commercial  radioimmunoassay  reagents 
(Thromboxane B2,  [3H]-RIA kit;  New  England Nuclear) (27). Recoveries  of TxB2 in 
extracted media were >98% as determined with [SH]TxB~ standards. 
Results 
Removal of Rosetted Platelets 
Phase contrast microscopy revealed that adherent monocytes derived from 
peripheral blood mononuclear cell suspensions contained substantial numbers of 
platelets rosetted to  their surfaces.  Scanning electron microscopy (SEM) con- 
firmed these observations (Fig.  1 A and B) and distinguished rosetted platelets 
from monocyte membrane ruffling. Such platelets appeared swollen and there- 
fore activated by morphologic criteria.  The  average number of platelets per 
monocyte ranged from 3 to 5. Some lymphocytes (4-5 per 100 monocytes) were 
identified and cell clumping was evident (Fig.  1 A and B). 
When mononuclear cell suspensions were subjected to two sequential incuba- 
tions in  serum containing EDTA at  37°C  before plating,  subsequent surface- 
bound contamination was reduced to 1-2 platelets per 200 monocytes (Fig.  1 C 
and  D).  Virtually  no  lymphocytes were  seen,  cell  clumping  was  absent,  and 
spreading of individual cells was increased. 
Adherent monocytes prepared from SW-M, in contrast to monocytes contam- 
inated with rosetted platelets (M-P), were readily detached from plastic surfaces 
by incubation  in  Ca  ++- and  Mg+÷-free PBS  and gentle pipetting.  These  D-M 
readhered to plastic surfaces in medium containing serum (5%).  After SW-M 
detachment, a few platelets remained adherent in the original culture dishes. It 
was likely that these represented platelets that were concealed beneath adherent 
monocytes. 
Phospholipid Fatty Acid  Composition of M-P and SW-M.  Platelets  represented 
15-40% of the total cell protein in 8 h M-P cultures [3-5 platelets per mon0cyte, 
3.85 +_ 1.22 #g protein/106 platelets (28, 29), and 45-55 #g protein/106 purified 
monocytes]. However, as shown in Table I, the phospholipid fatty acid compo- 
sition of M-P was not significantly different from that of SW-M. This suggested 
a close similariy between monocyte and platelet phospholipid fatty acid compo- 
sitions and is in agreement with prior analyses (30). 
Monocyte Uptake and Incorporation of [SH]20:4  into Phospholipid.  Between 60 
and 70% of the [3H]20:4 (5-8 nM) provided in serum-containing medium was 398  HUMAN  MONOCYTE  ARACHIDONIC  ACID  METABOLISM 
FIGURE  1.  SEM of glutaraldehyde-fixed human monocytes. (a) Adherent monocyte culture 
prepared from peripheral blood mononuclear cells isolated by conventional gradient separation 
techniques (M-P).  Individual monocytes have platelets and  occasional lymphocytes (arrows) 
attached  to their surfaces,  x  1,000.  (b)  M-P culture  containing monocytes with prominent 
membrane ruffling (open arrow). Variable numbers ofrosetted platelets (mean 3-5/monocyte) 
can be seen (solid arrows). X 3,000. (c) Adherent monocyte culture prepared from mononuclear 
cells  washed  in  serum-EDTA  prior  to  plating  (SW-M).  The  culture  contains  well-spread 
monocytes without lymphocyte contamination,  x  1,000. (d)  SW-M culture containing mono- 
cytes  with  prominent  membrane  ruffling  (open  arrows),  but  only  1-2  platelets  per  200 
monocytes were visible, x  3,500. 
TABLE  I 
Phospholipid Fatty Acid Compositions  of  Monocyte Preparations* 
Monocyte  Mole percent of fatty acid 
preparation  16:0  18:0  18:1  18:2  20:4 
M-P  24.8 4- 0.8  21.2 4- 0.6  20.7 4- 0.7  7.7 ±  0.6  25.6 ±  0.9 
SW-M  24.8 =t: 0.8  21.7 4- 0.4  21.4 4- 1.I  8.6 +  0.6  23.5 4. 0.9 
*M-P and SW-M cultures were established from a single blood sample as described in Materials and 
Methods. After an initial 2-h adherence period, cultures were washed and maintained in medium 
containing  10% serum  for an additional  4  h.  The adherent  cells were then  washed  thoroughly, 
placed on  ice, and  scraped into isotonic saline. Cellular lipids were extracted, and the fatty acid 
methyl esters were analyzed by gas-liquid chromatography after separation  of phospholipids and 
transesterification.  The data represent the mean +  SD of seven determinations for each type of 
monocyte preparation. PAWLOWSKI ET AL. 
TABLE II 
Distribution of  Incorporated [SH]20:4 in Phospholipids  of  Monocytes 
and Platelets* 
Percent of total in phospholipids  Cell prepa- 
ration  PC*  PE  PI  PS  DPG  SPH 
M-P  54.0  20.2  19.7  2.7  2.8  0.6 
SW-M  55.4  21.9  18.2  2.7  1.5  0.3 
Platelet  !  49.5  13.2  28.3  5.6  1.4  0.2 
*Cultures were established as described in Materials and Methods. After 
an initial 2-h adherence period, cultures were washed and incubated with 
medium containing 10% serum and [SH]20:4 (0.5 t~Ci) for 4 h. Monolay- 
ers were then washed thoroughly and the cellular lipids were extracted 
after scraping cells into isotonic saline. Aliquots of concentrated extracts 
were then subjected to two-dimensional  thin layer chromatography. The 
areas of chromatograms containing lipids were scraped and the radioac- 
tivity in each was determined.  Data are expressed as the percentage of 
the total radiolabel recovered  in all phospholipid species. Results are 
presented  for the mean obtained from two experiments performed in 
duplicate with M-P and SW-M cultures and one experiment performed 
in duplicate with adherent platelet cultures. In all determinations for 
each type of  cell preparation, results varied by <4% for each phospholipid 
species. 
*PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphati- 
dylinositol; PS, phosphatidylserine; DPG, diphosphatidyl glycerol; SPH, 
sphingomyelin. 
IThe radioactivity recovered in lysophosphatidylcholine  and phosphatidic 
acid represented ~3% of the total recovered in phospholipids. 
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taken up in 4  h  by M-P and SW-M cultures (45-110 #g protein/dish).  Uptake 
increased progressively to 80% by  12 h  with no further increase by 24 h. The 
absolute amount of radiolabel incorporated on a  per cell protein basis was not 
significantly different in M-P and SW-M cultures containing similar amounts of 
protein (80.8 __+ 11.4 and 80.3 _+ 6.9 gg/dish, respectively). 
After a  4-h incubation  of M-P or SW-M  cultures with [SH]20:4,  81-85%  of 
the cell-associated radiolabel was esterified into phospholipids.  Phosphatidylcho- 
line contained >50% of the label in both M-P and SW-M phospholipids, and the 
isotope distribution  among other phospholipids was  similar in  SW-M and  M-P 
(Table II). At times up to 24 h, the radiolabel content of phosphatidylethanola- 
mine increased progressively, whereas that of phosphatidylcholine and phospha- 
tidylinositol decreased proportionately. 
>95% of [3H]20:4 taken up by adherent platelets was recovered in phospho- 
lipid  and  its  distribution  among  phospholipid  classes  was  similar  to  that  of 
adherent monocytes (Table II) and  to platelets  in suspension  (31).  This result 
indicated that platelets contaminating M-P cultures do not alter the distribution 
of incorporated [SH]20:4 among cell phospholipids. 
Release of Incorporated [SH]20:4  by A23187.  Exposure  to  1  tzg/ml  calcium 
ionophore A23187  for 20  min  released comparable percentages of radiolabel 
from M-P (22.8 +  2.8%), SW-M (21.2 +  8.1%), and D-M (22.1  +  7.5%) cultures. 
Release  of radiolabel  was  maximal  by  15  min  in  M-P  cultures  at  ionophore 
concentrations of 1-10 #g/ml.  Although  radiolabel release increased with the 
dose of A23187  (30.3  +  2.5%  with  10 #g/ml),  HPLC analyses indicated  that 400  HUMAN  MONOCYTE  ARACHIDONIC  ACID  METABOLISM 
this was mainly accounted for by unreacted 20:4. In comparison, purified platelet 
monolayers labeled  with  [3H]20:4  released  23.0  _+  4.4%  of their  radiolabel 
content after exposure to A23187 under similar conditions. 
It is notable that exposure of monocytes to  1 #g/ml A23187 in serum-less 
medium reduced cell viability. After 15 min, most monocytes became nonadher- 
ent and <10% were viable. 
20:4  Metabolism  by  Monocytes and  Platelets  Stimulated  with  A23187.  Fig.  2 
compares the HPLC elution profiles of radiolabeled metabolites recovered from 
the media of M-P, D-M, and platelet cultures treated with A23187. The propor- 
tions of cyclo-oxygenase and  lipoxygenase products differed for each type of 
culture (Table III). Platelets converted the greatest percentage of released 20:4 
to cyclo-oxygenase products, and 12-HETE represented the single major iipox- 
ygenase product. In monocyte preparations, the proportion of cyclo-oxygenase 
products decreased by one-fourth with increased monocyte purity (D-M versus 
M-P). These same cultures also showed a sevenfold reduction in 12-HETE and 
a  2.3-fold increase in 5-HETE (Table III). As a result, 5-HETE accounted for 
75%  (SW-M)  to  84%  (D-M)  of the total  mono-HETEs in  purified monocyte 
cultures. Measurements of the molar quantities of 5- and  12-HETE from UV 
absorbance (240 rim) of HPLC effluents confirmed these observations (Fig. 2). 
The continued production of high levels of cyclo-oxygenase products, di-HETEs, 
and 5-HETE by SW-M and D-M indicated these were monocyte derived. These 
data indicated that platelets contribute to the 20:4  metabolites of ionophore- 
stimulated M-P preparations and that the ratio of 5- to 12-HETE is a convenient 
monitor of platelet contamination. 
Stimulation  with Monocyte- and Platelet-spec~c  Stimuli.  OpZ  or  Ig-beads pro- 
moted the release (15-18%) of [~H]20:4  from 8-h cultures of M-P, SW-M, and 
D-M by 60 min. OpZ was readily ingested by monocytes while the large Ig-beads 
(50 #m diam) remained bound to monocyte surfaces. Incubation of platelets with 
either particle did not lead to morphologic changes, surface binding, or release 
TABLE  III 
20:4 Metabolites Released by Monocytes and Platelets Stimulated with A23187" 
20:4 Metabolites 
Percent of total oxygenated metabolites 
Platelets  M-P  SW-M  D-M 
Cyclo-oxygenase  53.9 _  4.9  31.8 _  7.0  24.5 _  6.0  24.2 +  8.0 
Mono-HETEs 
12-HETE  29.7 _  8.1  20.8 +  8.2  6,7 _  1.8  3.2 +  0.6 
5-HETE  0  16.0 _  5.3  30,0 _  3.7  36.4 +  6.5 
Di-HETEs  5.0 +  1.2  21.9 +_ 5.0  27,0 _+ 5.0  24.4 +  8.7 
Other  11.4 +  3.5  9,5 4-_ 2.2  11,8 +  3.5  11.9 -+ 4.7 
*Radiolabeled cultures were  prepared as described in  Materials and  Methods. All cultures were 
stimulated with A23187 (1 #.g/ml) for 20 min in the absence of serum. Media were extracted and 
the organic phases were dried and subjected to reverse-phase HPLC using system 1. The radiolabel 
recovered in individual cbromatogram peaks are expressed as percentages of the total oxygenated 
metabolites recovered. The mean _+ SD of the results obtained from 5  to  12 determinations for 
each type of culture are presented. Representative chromatograms  are shown in Fig. 2. The elution 
times of individual 20:4 metabolites in this system  are described in the legend of Fig. 1 and Materials 
and Methods. Cyclo-oxygenase metabolites refer to the total radiolabel content in HPLC fractions 
in which stable cyclo-oxygenase  products (6-keto PGF~, PGF2~, PGE2,  TXB2, and HHT) elute. PAWLOWSKI  ET  AL.  401 
of incorporated [3H]20:4 above control levels (1-2.5%). 
HPLC profiles of radiolabeled compounds produced in response to OpZ (M- 
P, SW-M,  and D-M)  and Ig-beads (M-P  and SW-M) were similar, but distinct 
from those from A23187-stimulated monocytes. As shown in Fig. 3, the exposure 
of  M-P  or  SW-M  to  OpZ  induced the  synthesis  of mainly  cyclo-oxygenase 
products (47-58% of the total 20:4 metabolites). Substantially smaller amounts 
of lipoxygenase  products  (<18%  di-HETEs  and  <12%  mono-HETEs)  were 
released than with A23187-challenged cells (Table III). 
The adherent platelet response (23.6  +  6.0%  release of cell radiolabel) to 
thrombin was maximal at  1 U/ml (1-10  U/ml tested) and equivalent to that 
induced  by  1  #g/ml  of  A23187  at  20  min  (23.0  +  4.4%).  Identical  20:4 
metabolites were released by thrombin- and A23187-treated platelets.  No ra- 
diolabel release was observed when adenosine diphosphate (5 uM), collagen (100 
~g/mi), or epinephrine (5 I~M) was added to the medium of adherent platelets. 
SW-M  responded only slightly to thrombin in keeping with their low platelet 
levels (Table IV). In contrast, the thrombin response of M-P was >50% of that 
promoted with the ionophore A23187 (Table IV). 
The major radiolabeled metabolites released by thrombin-treated M-P (Fig. 
4A) corresponded to those isolated from A23187-stimulated platelets (Fig.  2B). 
In contrast, the small quantity of radiolabel released by SW-M incubated with 
thrombin was primarily unreacted 20:4 (Fig. 4A). As has been noted in platelets 
(32), thrombin treatment inactivated the cyclo-oxygenase and lipoxygenase activ- 
ities of monocytes. Exposure of M-P or SW-M to A23187 (20 min) immediately 
after a 20-min thrombin incubation resulted in the release of free [SH]20:4  (Fig. 
4B). 
Cyclo-oxygenase Metabolites Synthesized by Pur~ed Monocytes.  Fig. 5 shows HPLC 
elution profiles of the cyclo-oxygenase  products synthesized by SW-M in response 
to  A23187  and monocyte-specific stimuli (OpZ and Ig-beads).  The retention 
times of individual metabolites were identified by comparison with standards. 
With each of the three stimuli, similar elution profiles were obtained. TXB2 was 
the major cyclo-oxygenase product (61-81%) irrespective of the applied stimulus. 
PGE2  (10-16%),  PGF2~ (5-13%),  and  6-keto  PGFI~ (4-10%)  individually ac- 
counted for smaller proportions of the total radiolabeled cyclo-oxygenase metab- 
olites. Stimulation with monocyte-specific agents resulted in a higher proportion 
of TXB2  (76-81%)  than  with  A23187  (61%)  (Fig.  5).  This  represented  an 
increase from 3.5 to 8 in the TXB2/PGE2 ratio. Cyclo-oxygenase and lipoxygen- 
ase metabolites synthesized by purified monocytes are summarized in Table V. 
The molar quantities of TXB2 synthesized by monocytes are shown in Table 
VI. Removal of platelets from monocytes decreased TXB~ synthesis in response 
to A23187 by 50% (M-P vs. D-M); this was consistent with the radiolabel data 
(above). However, monocyte thromboxane synthesis was consistently higher with 
OpZ than with A23187. On a per ag cell protein basis, the level of TXB~ release 
by  monocytes exposed to  OpZ  was comparable to  that  of adherent platelets 
chailengedwith A23187 or thrombin. 
Effect of Culture Time on [~H]20:4  Metabolism.  M-P and SW-M cultures were 
maintained in medium containing serum for various intervals before exposure 
to A23187. At 8 h in culture, both types of cultures released comparable levels 
of radiolabei (23-28%). However, with longer times in culture the level of release 
fell.  The  loss  of response  was  more  rapid  in  SW-M  than  in  M-P  (Fig.  6). 
Furthermore, the percentage of released radiolabel recovered as unreacted 20:4 402  HUMAN  MONOCYTE  ARACHIDONIC  ACID  METABOLISM 
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FmURE  2.  Representative HPLC profiles of the 20:4 products released by adherent (A) M- 
P, (B) platelets, and (C) D-M after incubation with 1 #g/ml A23187 for 20 rain. SH content 
(--), and UV absorbance (240 nm) (--) of HPLC  effluents. Cultures were labeled with [3H] 
20:4, washed, and exposed to A23187 in medium without serum as described in Materials and 
Methods. After centrifug~ation, the media were extracted, dried under N2, and subjected to 
HPLC  using system  1.  Under these conditions, SH-labeled prostaglandin and thromboxane 
standards eluted at 4-11  min, di-HETEs at 12-16 rain, HHT at 17-18 rain, mono-HETEs at 
30-50 min, and unreacted 20:4 at 71-80 min. Elution times of 15-HETE (31-33 min),  12- 
HETE (36-38 min), and 5-HETE (42-45 min) were determined using standards. PAWLOWSKI  ET  AL.  403 
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increased as a function of culture time (21% at 8 h, 40% at 24-48 h, and 61% 
at 120 h in SW-M cultures), indicating that a smaller percentage of the released 
20:4 was being metabolized. Culture time also decreased [SH]20:4 incorporation 
into the phospholipids of both M-P and SW-M. 
It should be noted that culture for 24 h did not result in elimination of platelet 
contamination in  M-P cultures since A23187  stimulation resulted in the same 
proportion of 12-HETE relative to 5-HETE as in 8-h cultures. 
Discussion 
Human monocytes are commonly isolated by density gradient techniques (13) 
from  the  mononuclear  cell  populations  of peripheral  blood.  These  contain 
substantial  numbers of free-floating platelets which, because of their buoyant 
density, can be eliminated by repeated washing in buffer. However, individual 
adherent monocytes obtained from such preparations have an average of 3-5 
platelets specifically rosetted to their surfaces. Rosetted platelets are not removed 
by  simple  washing  with  buffer and  represent  the  major  contaminant  in  the 
routinely prepared monocytes (M-P) used in this study. These platelets could be 
dissociated from monocyte surfaces by incubating mononuclear cells in whole 
serum containing 5  mM EDTA at  37°C.  The resulting cultures (SW-M) were 
shown  by  SEM  to  contain  <1  platelet  per  100  monocytes (Fig.  1C  and D). 
Additional evidence for the absence of platelets was the lack of significant levels 
of 20:4 release, as opposed to M-P, when exposed to the platelet-specific stimulus 
thrombin (Table IV). 
The basis for platelet adherence to monocyte surfaces and their dissociation 
in serum-EDTA remains to be determined. However, rosetted platelets consist- 
ently showed the morphologic criteria of prior activation. This suggested the 
involvement of the coagulation process. In this regard, monocytes are obtained 
in low yields from defibrinated whole blood (13) and both mononuclear phago- 404  HUMAN  MONOCYTE  ARACHIDONIC  ACID  METABOLISM 
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F=GURE 3.  HPLC profiles of the 20:4 products released by adherent cultures of (A) M-P or 
(B) SW-M incubated with OpZ for 60 rain. 3H content (--) and UV absorbance (240 nm) (--) 
of HPLC effluents. SH-labeled cultures were prepared as described in Materials and Methods. 
Following exposure  to  OpZ,  culture  media  were centrifuged and  extracted.  After drying 
under N~, extracts were subjected to HPLC  using system  1 as described in  Fig.  2.  Similar 
HPLC profiles were obtained with D-M exposed to OpZ and with M-P or SW-M incubated 
with Ig-beads. Elution times of standards are given in Fig. 2. 
cytes and platelets bind fibrin or fibrinogen (33-36). 
Our results indicate that platelets can contribute 15-40% of the radiolabeled 
20:4 metabolites in short-term mixed cultures (M-P)  challenged with A23187 
and  that  platelets  remained  functional  for  up  to  24  h  in  culture.  Platelets 
therefore complicate the study of monocyte 20:4 metabolism. The requirement 
of freshly explanted cells for study emphasized this problem. 
The  identification  of monocyte-specific 20:4  metabolites  rested  upon  the 
elimination of contaminating platelets. This was especially important since TXB2, 
a well-known product of platelets (37), was the major cyclo-oxygenase product PAWLOWSKI ET  AL. 
TABLE IV 
[~H]20:4 Uptake and Release by Monocytes* 
405 
Release of incorporated [~H]20:4  !  Monocyte  Uptake* 
preparation  Control  A23187  Thrombin 
M-P  9,411± 1,095  580+78  1,7954-41  1,1174-65 
(6.2 +- 0.8)  (19.3 _ 0.4)  (12.6 + 0.7) 
SW-M  9,806 4- 2,050  442 4- 31  1,492 4- 593  539 4- 33 
(4.6 4- 0.4)  (15.4 4- 6.0)  (5.6 4- 0.4) 
*Each type of culture was prepared as described in Materials and Methods. After a 4-h exposure to 
[SH]20:4 in medium with serum, all cultures were washed and overlaid with medium without serum. 
Triplicate culture dishes of each cell preparation  were incubated for 20 rain with medium alone 
(control), A23187  (1  ttg/ml),  or human  thrombin  (1  U/ml). The media were then removed, 
centrifuged to remove cellular debris, and the radioactivity content was determined. Adherent cells 
from control  plates were washed and  the radiolabel and  protein  contents  of cell lysates were 
determined.  Results are given for a representative experiment in which M-P and SW-M cultures 
isolated from a single blood sample contained nearly identical average protein contents per culture 
dish. 
*Uptake (mean _  SD dpm/ttg cell protein) of radiolabel was determined  from triplicate control 
cultures. 
0Release of incorporated  [Sill20:4 (mean "4" SD dpm/ttg  cell protein)  was calculated from the 
radiolabel content of the medium (after incubation with medium alone or the indicated stimulus for 
20 min) divided by the mean protein content of the appropriate control culture dishes. The numbers 
in parentheses are the percent (mean + SD) of total radiolabel content released. 
of monocytes.  Once  this  was  achieved,  useful biochemical  markers  of platelet 
and monocyte metabolism became apparent. As shown previously (37), 12-HETE 
is  the  predominant  mono-HETE synthesized  by platelets,  whereas  monocytes 
produced  5-HETE,  The ratio of these metabolites then could be employed in 
monitoring monocyte purification.  Low levels of 12-HETE production by SW- 
M  may indicate trace platelet contamination. However, our data do not exclude 
the possibility that monocytes contain a  12-1ipoxygenase. 
Platelet- and monocyte-specific stimuli were helpful in identifying the products 
generated by each cell type. Thrombin promoted the release and metabolism of 
20:4 to TXB~ and  12-HETE by purified adherent platelets. The similar array of 
oxygenated 20:4 products obtained when M-P were challenged with thrombin 
were therefore indicative of platelet and not monocyte biosynthesis. The speci- 
ficity of the thrombin  stimulus for platelets was further assured by the lack of 
response by SW-M and D-M. In contrast, monocytes released high levels of 20:4 
metabolites in  response  to OpZ  or Ig-beads,  but platelets failed to respond to 
either  particle.  Cultures  of  M-P  exposed  to  these  particles  generated  20:4 
metabolites identical to those of purified monocytes (SW-M and D-M). 
Purified monocytes in culture (SW-M and  D-M) challenged with particles or 
A23187  released similar  percentages of their radiolabel  contents (15-18%  vs. 
15-25%).  After  incubation  with  either  OpZ  or  Ig-beads,  40%  of  the  20:4 
metabolites were cyclo-oxygenase products (Table V). TXB2 was the single major 
metabolite (25%) while lipoxygenase products (mono- and di-HETEs) accounted 
for 30%  of the  total.  In  contrast,  exposure to A23187  (2  #M)  resulted in  the 
synthesis of predominantly lipoxygenase products (70%, Tables III and V) and 
cell death.  5-HETE was the single major metabolite (27%) and the proportions 
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FXC,  UltE 4.  HPLC  profiles of the  [SH]20:4  products  released  by  (A)  M-P and  (B)  SW-M 
cultures after sequential treatment with 1 U/ml thrombin for 20 min (--) followed immediately 
by  I  #g/ml A23187  (--).  SH-labeled cultures were prepared as described in Materials and 
Methods. After thorough washing, cuhures were overlaid with fresh medium and thrombin 
was added. At 20 min, the media were removed and replaced with fresh media. A23187 was 
added immediately and cultures were incubated for an additional 20 min. The media from 
thrombin and  A23187  exposures were centrifuged and extracted.  After thorough  drying, 
extracts were subjected to HPLC as described in Fig. 2 (system 1). 
has a  specificity for the 5  position on the 20:4  molecule. Further evidence in 
support of this is the production of both leukotrienes B4 and C4 (to be reported 
separately). Of the cyclo-oxygenase products generated by A23187-treated mon- 
ocytes, TXB~ was again the predominant metabolite, but it represented a small 
percentage (7%) of the total 20:4 products. Thus, the balance of 20:4 metabolism 
via the cyclo-oxygenase  and lipoxygenase pathways in the monocyte is influenced 
by the nature of the stimulus. 
Activation of the 20:4 cascade was previously shown in murine macrophages 
(4) and human neutrophiis (38) to require the interaction of ligands with surface 
receptors.  It  is of interest that  Ig-beads on  the cell surface initiated  levels of 
radiolabel  release  and  metabolism  equivalent  to  those  of ingestible  particles 
(OpZ), both stimuli leading to the production of a similar array of 20:4 metabo- 
lites. 
The lipoxygenase products of human monocytes challenged with A23187 are 
similar to those recovered from human neutrophils incubated with higher con- 
centrations (20 #M) of the same stimulus and with or without exogenous 20:4 
(19). The highest percentage of 20:4 was converted to 5-HETE and a variety of 














~a  B 
la 
14 





FIGURE .5.  Representative HPLC profiles of the SH-labeled, stable cyclo-oxygenase metabo- 
lites released by cultures of SW-M incubated with (A) 1 #g/ml A23187, (B) OpZ, and (C) Ig- 
beads. (D) Elution profile of SH-labeled standards. Adherent SW-M cultures were established 
and labeled with [all]20:4 as described in Materials and Methods.  After exposure to  the 
indicated stimulus, culture media were centrifuged, extracted, and thoroughly dried before 
HPLC. The cyclo-oxygenase products initially separated using HPLC system 1 (4-11 rain) or 
system 2 (4-18 rain) were dried and rechromatographed using HPLC system 3. Unidentified 
radiolabeled products elute at the solvent front (2-7 min) and after 50 min. 
metabolites released by human neutrophiis in response to inflammatory stimuli 
remain to be determined. Thromboxane is the principal cyclo-oxygenase product 
of platelets (37) and neutrophils (20, 38) as well as monocytes. Thus, these three 
classes of circulating cells are strikingly similar in their production of a potent 
mediator of vasoconstriction and platelet aggregation (39) and have the potential 
of exerting similar influences within the vasculature during an  inflammatory 
response. From our results and those of others (37, 40), it is evident that the 
monocyte (0.83 pmol/#g cell protein) compares favorably with the platelet (0.84 
pmol/#g cell protein) in its capacity to synthesize TXB2 (Table VI), whereas the 
neutrophil (0.003 pmol/~g cell protein) has considerably less synthetic potential 
(38). 
No previous information existed concerning the spectrum of 20:4 metabolites 408  HUMAN  MONOCYTE  ARACHIDONIC ACID  METABOLISM 
TABLE  V 
Synthesis of 20:4 Metabolites by SW-M Exposed to A23187 or 
Particulate Inflammatory Stimuli* 
20:4 metabolites 
Percent of total oxygenated 
metabolites* 
A23187  OpZ  Ig-Beads 
Cyclo-oxygenase 
6-ketoPGF~  1.1  2.0  1.2 
TxB~  7.1  23.4  24.3 
PGF~,  1.5  2.6  1.5 
PGE~  1.9  2.9  3.0 
HHT  5.4  16.0  13.0 
Total  17.1  46.9  43.0 
Lipoxygenase 
mono-HETEs  ! 
di-HETEs 
Other  I 
Total 
41.3  ~12.0  ~12.0 
28.9  ~18,0  ~18.0 
70.2  ~30.0  ~30.0 
12.7  23,1  26.0 
*Radiolabeled  SW-M cultures were established as described  in Materials 
and Methods. After washing, cultures were overlaid with fresh medium 
and incubated with A23187 (1  #g/ml, 20  rain), OpZ (60 rain), or lg 
beads  (60  min).  The media were  then  removed and extracted.  The 
organic phases of extracts  were  dried and subjected  to reverse-phase 
HPLC with  system 2.  Retention times of individual products are de- 
scribed in Materials and Methods. Fractions containing  cyclo-oxygenase 
products were  rechromatographed using system 3.  After HPLC,  75- 
90% of the radiolabel recovered from medium extracts  in all instances 
represented oxygenated metabolites of [SH]20:4. 
*Results are presented as the percent of the total  oxygenated [3H]20:4 
products  recovered.  Of the  radiolabel  in  fractions  containing cyclo- 
oxygenase  metabolites,  an average  of 65-75%  represented individual 
cyclo-oxygenase products identifiable by retention time after rechroma- 
tography using HPLC system 3. These data were corrected by this factor. 
Results are presented for three experiments with A23187  and two ex- 
periments with  OpZ and Ig-beads.  Similar proportions of total  cyclo- 
oxygenase  products,  mono-HETEs, and  di-HETEs were  found after 
HPLC analyses of medium extracts from M-P stimulated with OpZ or Ig- 
beads (n = 2 for each stimulus). 
IAfter stimulation of SW-M with A23187, 5- and 12-HETEs each repre- 
sented an average  of 75%  and  17%, respectively,  of the  total  mono- 
HETEs recovered (Table Ill). In contrast,  incubation with OpZ or lg- 
beads resulted in substantially smaller amounts of 5-HETE (0.5-5.0%) 
and 12-HETE (2.5-5.0%) among the total metabolites. The percentages 
of 5-HETE included that of its 6-1actone  form. 
IRefers to the sum of the unidentified  radiolabeled products recovered in 
individual  chromatograms (system 2). These included very polar material 
eluting at the solvent front and with prostaglandins  (10-16%) and, in 
addition, presumed mono-HETEs (4-6%) that eluted before  12-HETE 
and had retention times comparable  to 15-HETE.  In addition, varying 
amounts of leukotriene C4  were  recovered  and  are  included in this 
category. 
synthesized  by  human  monocytes.  Other  studies  concerning monocyte  20:4 
metabolism have focused largely on the synthesis of PGE2 (6-1 1), and through 
this  mediator the  monocyte has  been implicated in the  regulation of immune 
responses  (6)  and  myelopoiesis  (41).  Our  results  show  that  while  the  human PAWLOWSKI  ET  AL. 
TABLE  VI 




pmol TXB~/pg protein 
Thrombin  A23187  OpZ 
Platelets  0.88 +  0.18  0.80 +  0.20  -- 
M-P  --  0.88 4- 0.46  1.49 4- 0.57 
D-M  --  0.42 4- 0.06  0.83 4- 0.28 
*Adherent cultures of platelets and monocytes were prepared and main- 
tained in culture for 8 h in medium containing serum. Duplicate cultures 
from each preparation were labeled with [SH]20:4 and used for concur- 
rent determinations of radiolabel release and products  synthesized by 
HPLC analyses as described in Materials and Methods.  After washing, 
cultures were exposed to the appropriate stimulus (thrombin and A23187 
for 20 min and OpZ for 60 ~in) in medium without serum. The media 
were  then centrifuged and extracted.  Prior to  radioimmunoassay, ex- 
tracts were thoroughly dried under N~ and resuspended in assay buffer. 
The results represent the mean 4- SD 0tool TXB~ produced per pg cell 
protein in two (D-M) to four (platelets and M-P) separate experiments. 
For each monocyte or platelet preparation, assays for TXB2 were per- 
formed in duplicate with extracts from at least four individual culture 
dishes given the san~e stimulus. The results from a  single SW-M prepa- 
ration were similar to D-M. 
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FIGURE 6.  Release of incorporated [SH]20:4 by M-P (--) and SW-M (--) monocyte prepara- 
tions after increasing intervals of culture. Adherent M-P and SW-M cultures were prepared 
as described in Materials and Methods. Adherent cells were maintained in medium containing 
serum (15%) until 4 h before the indicated time points (8, 24, 48, 72, 120, and 168 h). Cultures 
were then washed and exposed to [SH]20:4 in medium containing 10% serum for 4  h. Fresh 
medium was added after thorough washing and cultures were incubated with 1 pg/ml A23187 
for 20 rain. Radiolabel release was determined by scintillation counting in aliquots taken from 
centrifuged  media.  The  percentage  of radiolabel  released  was  calculated  using  the  total 
radiolabel content of control cultures given no stimulus. 410  HUMAN MONOCYTE ARACHIDONIC ACID METABOLISM 
monocyte produces low levels of PGE2,  the primary cyclo-oxygenase product 
formed is thromboxane, regardless of the applied stimulus. 
Summary 
Purified human  monocytes release and metabolize endogenous arachidonic 
acid (20:4)  from phospholipid  stores when challenged with particulate inflam- 
matory stimuli or the calcium ionophore A23187.  Using radiolabeled cultures, 
the percentage of total [3H]20:4 released was similar with each type of stimulus. 
However, the spectrum of 20:4  metabolites differed. With opsonized zymosan 
(OpZ) or Sephadex beads coated with  IgG immune complexes (Ig-beads), the 
predominant product was thromboxane (25% of the total) together with smaller 
amounts of other cyclo-oxygenase products and lipoxygenase metabolites. Levels 
of thromboxane synthesis by monocytes were comparable to those by platelets, 
as measured by radioimmunoassay. In contrast, exposure to the nonspecific agent 
A23187 led to mainly lipoxygenase products (70% of the total). 
Monocytes isolated from mononuclear cell fractions of peripheral blood con- 
tain platelets specifically rosetted to their surfaces. These platelet contaminants 
were removed by  sequential  incubations  of monocytes in  serum and  EDTA 
followed by adherence and detachment from tissue culture vessels. The presence 
of platelets in routinely isolated monocytes presented a  major difficulty in the 
study of human monocyte 20:4 metabolism since platelets also synthesize throm- 
boxane.  Loss of 12-HETE synthesis (16-fold reduction relative to 5-HETE) in 
A23187-stimulated cultures provided a convenient measure of platelet depletion. 
This together with the response to monocyte-specific stimuli (OpZ and Ig-beads) 
allowed for the distinction between monocyte and platelet 20:4 metabolism. 
Received for publication 8 April 1983. 
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